Search KLH Site
Find Articles by Tags
Addiction (18) Adjuvant - Alum (1) Adjuvant - GPI-0100 (1) Adjuvant - IL-4 (9) Adjuvant GM-CSF (16) Adjuvant KLH (4) Adjuvant Oil / Surfactant (4) Adjuvant QS-21 (25) Age & Physical Activity (3) Allergen-specific immunotherapy (1) Allergy – Pollen (2) Alzheimer's Disease (3) Antibody Response (35) Antibody Response IgA (14) Antibody Response IgE (6) Antibody Response IgG (106) Antibody Response IgM (71) Antibody Response IgY (1) APEC (1) Assay - Bioassay (2) Assay - Carbohydrate Microarray (1) Assay - ELISA (55) Assay - ELISPOT (7) Assay - Immunoassay (8) Assay - InVitro (18) Assay - InVivo (1) Atopic Dermatitis (1) Autoimmune Disease (1) B-epitope (1) Bone Marrow Transplant (6) Cancer (6) Cancer - Bladder (16) Cancer - Brain & CNS (8) Cancer - Breast (15) Cancer - Cervical (1) Cancer - Colorectal (10) Cancer - Esophageal (1) Cancer - Female Reproductive (7) Cancer - Leukemia (2) Cancer - Lung (4) Cancer - Lymphoma (25) Cancer - Melanoma (37) Cancer - Mesothelioma (1) Cancer - Myeloma (15) Cancer - Other (2) Cancer - Ovarian (3) Cancer - Pancreas (1) Cancer - Pediatric (3) Cancer - Peritoneal (2) Cancer - Prostate (9) Cancer - Renal (13) Cancer - Sarcoma (2) Clostridium difficile (5) Crohn's Disease (2) Cross-Reactive Antigens (6) Delayed-type hypersensitivity response (1) Dendritic Cell (66) Developmental (10) Diabetes (2) Disease Resistence (1) DNP-Ficoll (2) DTH (67) Environmental (15) Escherichia coli (1) Fingolimod (Gilenya) (1) Healthy Volunteers (18) HealthyAntibody Response - IgA (1) Hepatitis (2) HIV (11) HPV (3) Husbandry (3) Hypertension (1) id-KLH (29) IL 1 (4) IL 12 (2) IL 15 (1) IL 2 (10) IL 5 (1) IL 6 (1) IL 7 (1) Immune Disease - Autoimmune (13) Immune Disease - Primary (2) Immune Disease – Secondary (1) Immune Response - Cellular (187) Immune Response - Humoral (259) Immune Response Humoral (2) Immunotoxicity (37) Infection (1) Infectious Disease (5) Inflammatory Disease (1) Intradermal KLH (1) Kidney (1) KLH-BEC2 (1) KLH-BP16 (1) KLH-BPO (1) KLH-Conjugate (69) KLH-EGFR (2) KLH-FITC (1) KLH-Ganglioside (16) KLH-Globo H (7) KLH-GM2 (1) KLH-hD1 (1) KLH-HGP-30 (1) KLH-IL (1) KLH-Kinoid (8) KLH-Lewis Y (3) KLH-MUC (8) KLH-Oxycodone (2) KLH-sTn (9) KLH-TF (5) KLH-TN (3) Model - Canine (6) Model - Guinea Pig (10) Model - Livestock (10) Model - Mouse (73) Model - Other (32) Model - Primate (12) Model - Rat (51) Multiple Sclerosis (1) Nasal (3) Natrural Antibody (1) Neonatal (2) NK Cells (1) NSAID (1) Oral KLH (9) Oxycodone (3) Parasitic Disease (6) Pediatric (1) Plant-made (2) PLNA (1) Population Density (3) Psoriasis (1) Review Article (2) Rheumatoid Arthritis (11) Rituximab (Rituxan) (4) Russian thistle (1) Sal k 1 (1) Stress (8) Systemic Lupus Erythematosus (SLE) (7) TACA (2) TDAR (127) Therapeutics - KLH Alone (15) Transplant (6) Ultra Violet radiation (1) Uveitis (1) VEGF (3) Veterinary (1)
Terms and Privacy

KLH in Publications

Publications of scientific research involving KLH. Abstracts or full text articles are available by link to outside sites. If you know of a KLH-related publication that is not yet on KLH Site™, let us know.

(in order by date)

Entries in Healthy Volunteers (18)

Wednesday
Feb012017

Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects

Rong Shi PhD, Marek Honczarenko MD, PhD, Sean Zhang MD, Catherine Fleener MS, Johanna Mora PhD, Sun Ku Lee PhD, Reena Wang MD, Xiaoni Liu PhD, Diane E. Shevell PhD, Zheng Yang PhD, Haiqing Wang PhD, Bindu Murthy PharmD.

J Clin Pharmacol. 2017 Feb;57(2):161-172. doi: 10.1002/jcph.791. Epub 2016 Aug 23.

Wednesday
Jun012016

FRI0230 Assessment of Safety, Pharmacokinetics and Pharmacodynamics of A Novel anti-CD40 Monoclonal antibody, CFZ533, in Healthy Volunteers and in Rheumatoid Arthritis Patients

A. SladeP. Koo, Y. He, P. Espie, A. Auger-Sarrazin, J. Rush, P. Gergely

Annals of the Rheumatic Diseases, June 2016; Vol 75, Issue Suppl 2.

Monday
Apr272015

Preexisting antigen-specific immune responses are modulated by oral KLH feeding in humans

Hostmann AMeyer TMaul J1Preiss JBoortz BThiel ADuchmann RUllrich R

Eur J Immunol. 2015 Jul;45(7):1991-6. doi: 10.1002/eji.201445024. Epub 2015 Apr 27.

Thursday
Aug012013

A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus

John Ferbas, Shelley S Belouski, Michelle Horner, Arunan Kaliyaperumal, Li Chen, Malcolm Boyce, C Bernie Colaço, Neil McHugh, Vanessa Quick, Richard J Nicholl, Gerald Siu, and James Chung

Br J Clin Pharmacol. 2013 Aug; 76(2): 188–202

Friday
Oct282011

Response to Cutaneous Immunization with Low-Molecular-Weight Subunit Keyhole Limpet Hemocyanin

Milgrom H, Kesler K, Byron M, Harbeck R, Holliday R, Leung DY.

Int Arch Allergy Immunol. 2011 Oct 28;157(3):269-27

Sunday
Jun122011

Humoral Immune Response to Keyhole Limpet Haemocyanin, the Protein Carrier in Cancer Vaccines

A. Kantele, M.P. Hakkinen, J. Zivny, C.O. Elson, J. Mestecky, and J.M. Kantele.

Clin Dev Immunol. 2011;2011:614383. Epub 2011 Jun 12

Tuesday
Oct192010

Modulation of systemic antigen-specific immune responses by oral antigen in humans

Kapp K, Maul J, Hostmann A, Mundt P, Preiss JC, Wenzel A, Thiel A, Zeitz M, Ullrich R, Duchmann R.

Eur J Immunol. 2010 Nov;40(11):3128-37. doi: 10.1002/eji.201040701. Epub 2010 Oct 19.

Wednesday
Oct132010

Effects of fingolimod on antibody response following steady-state dosing in healthy volunteers: a 4-week, randomised, placebo-controlled study

Thursday
Feb112010

Evaluation of human antibody responses to keyhole limpet hemocyanin on a carbohydrate microarray

Thursday
Feb192009

T helper 2 biased de novo immune response to Keyhole Limpet Hemocyanin in humans.

Spazierer D, Skvara H, Dawid M, Fallahi N, Gruber K, Rose K, Lloyd P, Heuerding S, Stingl G, Jung T.

Clin Exp Allergy. 2009 Jul;39(7):999-1008. Epub 2009 Feb 19.

Friday
Aug012008

Cardiovascular Exercise Intervention Improves the Primary Antibody Response to Keyhole Limpet Hemocyanin (KLH) in Previously Sedentary Older Adults

R.W. Grant, R.A. Mariani, V. J. Vieira, M. Fleshner, T. P. Smith, K.T. Keylock, T.W. Lowder, E. McAuley, L. Hu, K. Chapman-Novakofski, and J.A. Woods.

Brain Behav Immun. 2008 August; 22(6):923-932

Wednesday
Dec012004

Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration.

Moldoveanu ZOliver FMestecky JElson CO.

Ann N Y Acad Sci. 2004 Dec;1029:299-309.

Sunday
Aug012004

Influence of age and physical activity on the primary in vivo antibody and T cell-mediated responses in men.

Smith TP, Kennedy SL, Fleshner M.

J Appl Physiol. 2004 Aug;97(2):491-8.

Thursday
Jan012004

The relationship between distress and the development of a primary immune response to a novel antigen

Smith A, Vollmer-Conna U, Bennett B, Wakefield D, Hickie I, Lloyd A

 

Thursday
Feb011996

Pilot study of oral tolerance to keyhole limpet hemocyanin in humans: down-regulation of KLH-reactive precursor-cell frequency.

Matsui M1Hafler DAWeiner HL.

Ann N Y Acad Sci. 1996 Feb 13;778:398-404.

Sunday
Apr011990

Induction of an immune response to keyhole-limpet hemocyanin in surgical patients with anergy

Puyana JC, Rode HN, Christou NV, Meakins JL, Gordon J

Surgery. 1990 Apr;107(4):442-8

Tuesday
Jan011985

Modulation of immune response in aged humans through different administration modes of thymopentin

Duchateau J, Servais G, Vreyens R, Delespesse G, Bolla K

Surv Immunol Res. 1985;4 Suppl 1:94-101

Sunday
Jan011984

Immunomodulation with thymopentin in humans

Bolla K, Duchateau J, Delespesse G, Servais G

Int J Clin Pharmacol Res. 1984;4(6):431-8